Evidence map›Paper›PMID 18056482›Full record

ArticleBlood2008

Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation.

Jason W Chien, Michael J Boeckh, John A Hansen, Joan G Clark

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Synergy between acid and endotoxin in an experimental model of aspiration-related lung injury progression.American journal of physiology. Lung cellular and molecular physiology · 2015
    Article
  8. Article
  9. Article
  10. Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2012
    Article
  11. Article
  12. Review
  13. Article
  14. Genetic polymorphisms and posttraumatic complications.Comparative and functional genomics · 2010
    Article
  15. Article
  16. The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2009
    Article
  17. Improving hematopoietic cell transplant outcomes in a new era of genomic research.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2009
    Review
  18. Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2008
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jason W ChienClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA. jchien@fhcrc.org
Michael J Boeckh
John A Hansen
Joan G Clark
Fred Hutch Cancer Center · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
VIRUS-MEDIATED MYELOSUPPRESSIONP01CA018029 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Geoffrey Roger HILL · 1985 to 2026
$128.4M
TRANSPLANTATION IMMUNOLOGYP01AI033484 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MARTIN, PAUL J · 1992 to 2013
$13.1M
Whole Genome Association Analysis of Hematopoietic Cell Transplant OutcomeR01HL087690 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HANSEN, JOHN ANDREW · 2006 to 2008
$4.1M
Genetic epidemiology of TLR4 alleles and bacteremiaK23HL069860 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CHIEN, JASON W · 2002 to 2006
$776k
NCI NIH HHS CA15704NCI NIH HHS CA18029NCI NIH HHS P01 CA018029NCI NIH HHS P30 CA015704NHLBI NIH HHS HL87690NHLBI NIH HHS K23 HL069860NHLBI NIH HHS K23HL69860NHLBI NIH HHS R01 HL087690NIAID NIH HHS AI33484NIAID NIH HHS P01 AI033484
6 · The paper itself

Abstract

Lipopolysaccharide binding protein (LBP) function is dependent on circulating LBP levels. Disturbance of LBP transcription regulation may influence the risk for clinical events. In a nested case-control study using a single nucleotide polymorphism haplotype tagging (tagSNP) approach, we assessed whether genetic variation in the LBP gene influences the risk for Gram-negative (GN) bacteremia after allogeneic hematopoietic cell transplantation (HCT), then validated the association in a prospective cohort by correlating genetic variation with basal serum LBP levels and mortality. Presence of the tagSNP 6878 C allele among patients was associated with a 2-fold higher risk for GN bacteremia (odds ratio = 2.15; 95% confidence interval [CI], 1.31-3.52, P = .002). TagSNP 6878 was in strong linkage disequilibrium with 3 SNPs in the LBP promoter, one of which was SNP 1683 (r(2) = 0.8), located in a CAAT box that regulates LBP promoter efficiency. SNP 1683 was associated with higher median basal serum LBP levels (TT 8.07 microg/mL; TC 10.40 microg/mL; CC 17.39 microg/mL; P = .002), and a 5-fold increase in GN bacteremia related mortality after HCT (hazard ratio = 4.83; 95% CI, 1.38-16.75, P = .013). These data suggest that transcriptional regulation of the LBP gene contributes to the risk for developing GN bacteremia and death after HCT.

Indexed as

Genetic VariationTranscription, GeneticAcute-Phase ProteinsAdultCarrier ProteinsCase-Control StudiesCohort StudiesDNAFemaleGenotypeGram-Negative Bacterial InfectionsHematopoietic Stem Cell TransplantationHumansLipopolysaccharide-Binding ProteinMaleMembrane GlycoproteinsAcute-Phase ProteinsCarrier ProteinsDNALipopolysaccharide-Binding ProteinMembrane Glycoproteins

Identifiers

PMID18056482
PMCPMC2234070
OpenAlexW2063953590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.